Management Team

Nikki Hafezi, MAS IP ETHZ

Chief Executive Officer

Nikki Hafezi previously worked for the US National Science Foundation managing the IP portfolio and industrial relations of a biomedical research consortium comprised of three renown universities (California Institute of Technology, University of Southern California Los Angeles, University of Santa Cruz).

She has also been instrumental in creating and developing several academic start-up companies in the field of ophthalmology. Mrs. Hafezi holds a Master’s degree in Intellectual Property from the Swiss Federal Institute of Technology.

In 2015, Nikki Hafezi was voted onto the “Top 40 under 40” list of the British journal, “The Ophthalmologist” as being one of the “young, up-and-coming individuals set to rise to the top of the field.” Mrs. Hafezi was one of six females listed, and one of two nominees only representing industry.

nhafezi@emagine-eye.com

Farhad Hafezi, MD, PhD

Chief Scientific & Medical Advisor

Farhad Hafezi is recognized as one of the pioneers of corneal cross-linking (CXL). He was one of the founders of IROC AG (Zurich, Switzerland) who commercialized the first ultraviolet (UV) irradiation system for the use in corneal cross-linking in 2006. The concept of the C-Eye device is based on his and Dr. Olivier Richoz’ inventions. Farhad Hafezi holds professorships at the University of Geneva, Switzerland and USC Los Angeles. He has so far published more than 60 peer-reviewed scientific articles on cross-linking technology. He was first author on the first descriptions on the use of CXL in very thin corneas, and in postoperative ectasia after refractive laser surgery.

Since 2006, he co-organizes the international CXL meeting. He also is a founding member of the “Expert group on surgical options in the management of Keratoconus” of ESCRS and Editor of the textbook “Corneal cross-linking”, Slack Inc, New York, which will appear in its second edition in late 2016. In 2015, Prof. Hafezi was a member of the Delphi Panel, which re-defined the disease “keratoconus”.

In 2014 and 2016, Farhad Hafezi was voted by his peers onto the “PowerList” of the British Journal “The Ophthalmologist”. The “Power List” comprises the 100 most influential personalities in ophthalmology.

For more information, see Wikipedia.

fhafezi@emagine-eye.com